Sort
30,917 grants matching “tumor microenvironment”
STUDYING THE EFFECT OF PPARG PATHWAY MODULATION ON TUMOR IMMUNE MICROENVIRONMENT IN MUSCLE INVASIVE BLADDER CANCER
$248,559Health Research, Inc. · · FY2019 · Defense Health Agency
Paracrine Role of Endothelial Cells in HER3-Mediated Colon Cancer Cell Survival
$248,541Rui Wang · Case Western Reserve University · R00 · FY2022 · CA
Immune Microenvironments and Hepatocyte Growth Factor Signaling Interactions in Breast Cancer Disparities
$248,511Kevin Peter Williams · North Carolina Central University · U54 · FY2023 · MD
Development of Molecularly Targeted Imaging Agents for Early Detection of PDAC
$248,508Kimberly A. Kelly · University Of Virginia · R01 · FY2011 · CA
Development of Molecularly Targeted Imaging Agents for Early Detection of PDAC
$248,508Kimberly A. Kelly · University Of Virginia · R01 · FY2012 · CA
Project 3: Inhibiting Oxidative Phosphorylation in Pancreatic Cancer
$248,429Shubham Pant · University Of Tx Md Anderson Can Ctr · P50 · FY2021 · CA
Cell Migration Control through Modulation of Multiple Directional Cues
$248,424Ian Christopher Schneider · Iowa State University · R01 · FY2022 · GM
Intravesical rF-GMCSF and rF-TRICOM in the treatment of advanced bladder cancer
$248,411Edmund C. Lattime · Univ Of Med/Dent Nj-R W Johnson Med Sch · R21 · FY2006 · CA
Role of elF2a phosphorylation and ER stress in hypoxia tolerance and tumor growth
$248,411Constantinos Koumenis · University Of Pennsylvania · R01 · FY2011 · CA
T CELL THERAPY TARGETING MULTIPLE TUMOR ANTIGENS IN HODGKIN LYMPHOMA
$248,378Ann M. Leen · Baylor College Of Medicine · P50 · FY2012 · CA
Role of Immune Regulatory Pathways in BRAF Targeted Therapy In Melanoma
$248,370Arlene H Sharpe · University Of Tx Md Anderson Can Ctr · U54 · FY2012 · CA
Quantification of whole-body distribution and speciation of gadolinium-based contrast agents by Y-86 PET/MRI
$248,357Mariane Le Fur · Massachusetts General Hospital · R00 · FY2025 · EB
In situ anti-tumor immunity and effects of radiation
$248,343Edith M. Lord · University Of Rochester · R01 · FY2019 · CA
In Vivo Imaging Facility
$248,336Carolyn J Anderson · University Of Pittsburgh At Pittsburgh · P30 · FY2020 · CA
Project 2: Microenvironment Modification and Anti-PD1 Immunotherapy of Lymphoma
$248,267George J Weiner · University Of Iowa · P50 · FY2019 · CA
Leveraging Mammalian Cancers, Platinum-Quality Genome Assemblies, and Large-Scale Data to Identify Mechanisms of Rare Human Cancers
$248,259Kiley Graim · University Of Florida · R01 · FY2022 · CA
Memory-like NK cells for enhanced immunotherapy of post transplant relapse in patients with myeloid malignancies
$248,243Rizwan Romee · Dana-Farber Cancer Inst · R21 · FY2021 · CA
Low-Fat/Fish Oil Diet and prostate Cancer Outcomes in Human Cohorts and Mouse Mo
$248,227William J Aronson · University Of California Los Angeles · P50 · FY2015 · CA
Role of MUC1 in Pancreatic Cancer
$248,188Pinku Mukherjee · University Of North Carolina Charlotte · R01 · FY2009 · CA
Role of MUC1 in Pancreatic Cancer
$248,188Pinku Mukherjee · University Of North Carolina Charlotte · R01 · FY2010 · CA
microRNA therapies for advanced brain tumors
$248,165Deepak Bhere · University Of South Carolina At Columbia · R00 · FY2023 · CA
Oncolytic Immunotherapy of Malignant Glioma
$248,157Matthias Gromeier · Duke University · P50 · FY2017 · CA
IDENTIFICATION OF MOLECULAR BIOMARKERS FOR INVASIVE GLIOBLASTOMA CELL STATES AND TUMOR MICROENVIRONMENT MODULATION
$248,156Regents Of The University Of Michigan · · FY2025 · Defense Health Agency
Core 1: Administrative and Bioinformatics Core
$248,087Surinder Kumar Batra · University Of Nebraska Medical Center · P01 · FY2022 · CA
Core 2: Animal Model and Experimental Therapeutics Core [AMETC]
$248,086Maneesh Jain · University Of Nebraska Medical Center · P01 · FY2022 · CA